Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04975334
PHASE1

Opioid Antagonism in Hypogonadotropic Hypogonadism

Sponsor: Stephanie B. Seminara, MD

View on ClinicalTrials.gov

Summary

The goal of this study is to evaluate the effects of opioid antagonists on the hypothalamic-pituitary-gonadal axis in subjects with hypogonadotropic hypogonadism (HH).

Key Details

Gender

MALE

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

23

Start Date

2025-06-18

Completion Date

2025-09-26

Last Updated

2026-05-01

Healthy Volunteers

No

Interventions

DRUG

Naloxone

One bolus of naloxone

Locations (1)

Massachusetts General Hospital

Boston, Massachusetts, United States